Press release
PharmaResearch Announces 'Open Innovation Day' Running Until September 30 to Foster New Partnerships
Image: https://www.getnews.info/uploads/3276751a42ffba8429fb959e81d25795.jpg
PharmaResearch, a company specializing in regenerative medicine (CEO Kim Thinkyou, Kang Ki-seock), announced that it will host the 'Open Innovation Day'. This initiative aims to foster collaborations in innovative technologies across the aesthetic medical device, pharmaceuticals, biotechnology sectors, both domestically and internationally.
PharmaResearch is seeking partnerships in several key areas, including - facial aesthetics, - body contouring, - aesthetic devices and technology, and - treatments for hair loss, obesity, and sarcopenia. Medical device, Pharmaceutical and biotechnology companies from around the world with innovative technologies and expertise in these fields are encouraged to apply.
PharmaResearch is actively seeking to establish various forms of partnerships with selected companies, including licensing agreements, joint development initiatives, and strategic investments.
A representative from PharmaResearch stated, "The Open Innovation Day is designed to support the continuous growth of companies with innovative ideas and technologies through collaboration. We will continue identifying promising companies and establishing cooperative frameworks for mutual growth."
Applications for participation are open from August 15 to September 30. Detailed information about the 'Open Innovation Day' can be found in the notice section on the PharmaResearch website (https://pharmaresearch.co.kr/en/notice/list.html).
Image: https://www.getnews.info/uploads/8234b2c31f2d327c24f8286c5e4bf35c.png
About PharmaResearch
PharmaResearch is a pioneering biopharmaceutical company dedicated to enhancing the quality of life for humanity through regenerative medicine. With a diverse portfolio encompassing medicines, medical devices, cosmetics, and supplements, PharmaResearch focuses on leveraging its core ingredients, DOT Registered PDRN and DOT Registered PN. These active tissue regenerative substances are powered by DOT Registered , an exclusive DNA fragments optimization technology safeguarded by a suite of patents. Headquartered in Seongnam, South Korea, PharmaResearch also operates a U.S. subsidiary, PharmaResearch USA, located in Costa Mesa, California.
Key products include Rejuran Registered , Rejuviel Registered , Conjuran Registered , Rejuran Registered Cosmetics, Lian Registered Eye Drops, Rejuvenex Cream Registered , and Rejuderma Registered .
For more information about PharmaResearch and its innovative initiatives, visit
http://pharmaresearch.co.kr/en/ and connect with us on LinkedIn [https://www.linkedin.com/company/pharmaresearch-corporation/].
Media Contact
Company Name: PharmaResearch USA
Contact Person: Sangjin Choi
Email: Send Email [http://www.universalpressrelease.com/?pr=pharmaresearch-announces-open-innovation-day-running-until-september-30-to-foster-new-partnerships]
Country: United States
Website: http://pharmaresearch.co.kr/en/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PharmaResearch Announces 'Open Innovation Day' Running Until September 30 to Foster New Partnerships here
News-ID: 3651324 • Views: …
More Releases from Getnews
Michael Lissack's New Book "Questioning Understanding" Explores the Future of Sc …
Image: https://www.globalnewslines.com/uploads/2025/09/06b23a7a1cd3a9eec5188c16c0896a60.jpg
Photo Courtesy: Michael Lissack
"Understanding is not a destination we reach, but a spiral we climb-each new question changes the view, and each new view reveals questions we couldn't see before."
Michael Lissack, Executive Director of the Second Order Science Foundation, cybernetics expert, and professor at Tongji University, has released his new book, "Questioning Understanding [https://www.amazon.com/Questioning-Understanding-Michael-Lissack/dp/B0FC1S1LYL]." Now available, the book explores a fresh perspective on scientific inquiry by encouraging readers to…
VAYA VAYA Announces New Album Launch: "ELUSIVE THUGS" - A Powerful Exploration o …
Image: https://www.globalnewslines.com/uploads/2025/09/9ab56ab339d69d8f43f77805fa341de3.jpg
Photo Courtesy: VAYA VAYA
Toronto, Canada - Sep 5, 2025 - VAYA VAYA [https://www.instagram.com/vaya.vaya_am/], an acclaimed artist known for her bold and innovative music, is set to release her highly anticipated ALBUM 10 ELUSIVE THUGS, on August 9, 2025. The album, which features four powerful tracks, marks a pivotal moment in VAYA VAYA's musical career and showcases her unique ability to blend raw energy with thought-provoking themes.
Album Overview: A Journey…
Surviving in a Chaotic World: John Cologon's New Single "Don't Give in to Despai …
In a world that seems to be tipping further off balance by the minute, hope can be hard to come by. John Cologon's new release, "Don't Give in to Despair" addresses this issue head on.
Released September 5th, this upbeat and emotionally impactful song combines the best elements of rock, blues, funk and art pop with a strong beat that is energetic and danceable."I went through a period of doom scrolling,…
Oricle Hearing Transforms Hearing Health with Accessible, FDA-Registered OTC Sol …
Image: https://www.globalnewslines.com/uploads/2025/09/20e1f96f75669317346aaf11725f0c70.jpg
Oricle Hearing [https://www.oriclehearing.com/?utm_source=PR], one of industry's leading providers of FDA-registered over-the-counter (OTC) hearing aids, is pleased to announce that it is now offering highly affordable, doctor-free access to top quality hearing support for both adults and seniors with mild to moderate hearing loss.
When it comes to hearing challenges, it affects people of all age groups. However, most people avoid addressing these issues due to high costs, lengthy appointments and…
More Releases for PharmaResearch
Polynucleotides Injectable Overview and Leading Players: Euroresearch S, NeoGene …
The Polynucleotides Injectable market is rapidly gaining traction as a pivotal segment within the aesthetic and medical sectors. Polynucleotides, naturally occurring polymers of nucleotides, have emerged as a revolutionary ingredient in injectables, primarily due to their ability to stimulate tissue regeneration and enhance skin hydration. The relevance of this market is underscored by its applications in various therapeutic and aesthetic procedures, including skin rejuvenation, wrinkle reduction, and overall facial volumization.
𝐘𝐨𝐮…
PharmaResearch Hosts 5th Global Symposium on 'Rejuran'
Over 600 Medical Professionals from 25 Countries Participate, Launch of IRC Committee for Rejuran Global Research Team
Image: https://www.getnews.info/uploads/184db9fd8e5f5bcffadcfd0b82962264.png
Seongnam, South Korea - PharmaResearch (CEO Ki Seock Kang and Thinkyou Kim) announced today that it successfully held the 5th PharmaResearch Global Symposium (PGS) at the Lakai Sandpine Resort on October 28-29, 2024. This year's event attracted approximately 600 aesthetic and medical professionals from 25 countries across Asia, the Americas, Europe, and the…
PharmaResearch Accelerates Global Market Expansion with Investment from Global P …
Accelerating Overseas Expansion and Market Strengthening through CVC Partnership, M&As, and R&D Investments
Image: https://www.getnews.info/uploads/37d3d1ec3a03e85dac6376b2c2e3bb4e.jpg
September 13th, 2024 - PharmaResearch (co-CEOs: Kang Ki Seock, Kim Thinkyou), a leader in aesthetic injectables and regenerative medicines renowned for its flagship skin booster product "Rejuran", announced a significant milestone in its global market expansion efforts, securing KRW 200 billion investment from Europe-based global private equity firm CVC through the issuance of redeemable convertible preferred shares…
PharmaResearch Hosts Launch Symposium for REJURAN Registered HB Plus in Singapor …
Sharing information on DOT Trademark patented technology, distinctive efficacy, and safety
Image: https://www.getnews.info/uploads/a9dbc52352e6614785a6dbafd0148817.png
PharmaResearch (CEOs Kang Ki-seok and Kim Thinkyou), a company specializing in regenerative medicine, announced earlier this month that it held a launch symposium for REJURAN Registered HB Plus at Four Seasons Hotel in Singapore.
The symposium aimed to share the technological advancements and clinical experiences of REJURAN Registered HB Plus with local aesthetic experts and medical professionals.
Dr. Michael J. Kim,…
PharmaResearch Presents 'REJURAN Registered ' as a New Solution for Flushing
Effective Use of PN for Flushing... Published in an SCIE-Level Journal
Image: https://www.getnews.info/uploads/52b03d248c2ca7ae3fdd1f69ef67ba5c.png
Flushing refers to the temporary or persistent redness of the skin on the face and neck. It occurs due to vasodilation and is known to arise from various causes, such as hormonal changes, sudden temperature fluctuations, inflammatory skin diseases, and prolonged laser treatments.
While laser and hormone therapies are common treatments for flushing, PharmaResearch(CEO Kim Thinkyou, Kang Ki-seok) has recently…
PharmaResearch, "Rejuran Registered " Accelerates Entry into Vietnam
Rejuran Launch Symposium Highlights Latest Aesthetic Trends and DOT Trademark Technology
Image: https://www.getnews.info/uploads/94717ca7a950a52ac08fd7e65857e556.jpg
PharmaResearch (CEO Kim Thinkyou, Kang Ki-seok) announced the official entry into the Vietnamese market through the 'Rejuran Launch Symposium' held on May 17 at the Intercontinental Vietnam.
The symposium was attended by over 400 Vietnamese aesthetic experts and medical professionals who validated the excellence of Rejuran and engaged in in-depth discussions on its application methods.
'Rejuran' is a medical device aimed…
